These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 2458031)
1. Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. Vardiman JW; Gilewski TA; Ratain MJ; Bitter MA; Bradlow BA; Golomb HM Am J Clin Pathol; 1988 Sep; 90(3):250-6. PubMed ID: 2458031 [TBL] [Abstract][Full Text] [Related]
2. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders. Hoyer JD; Li CY; Yam LT; Hanson CA; Kurtin PJ Am J Clin Pathol; 1997 Sep; 108(3):308-15. PubMed ID: 9291460 [TBL] [Abstract][Full Text] [Related]
4. Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon-treated hairy cell leukaemia patients. Falini B; Pileri SA; Flenghi L; Liberati M; Stein H; Gerli R; Minelli O; Martelli MF; Lauria F; Poggi S Br J Haematol; 1990 Dec; 76(4):460-8. PubMed ID: 1702309 [TBL] [Abstract][Full Text] [Related]
5. B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells. Mulligan SP; Travade P; Matutes E; Dearden C; Visser L; Poppema S; Catovsky D Blood; 1990 Sep; 76(5):959-64. PubMed ID: 2118401 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow and splenic histology in hairy cell leukaemia. Wotherspoon A; Attygalle A; Mendes LS Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898 [TBL] [Abstract][Full Text] [Related]
7. Hairy cell leukemia and other "hairy-cell" lymphoproliferative disorders (LPD-HC): the significance of morphologic, histologic and immunologic studies. Yavorkovsky LL; Gipsh NM; Karminskaya NM; Udris OYu ; Nikulshin SV; Yavorkovsky LI Neoplasma; 1990; 37(4):439-44. PubMed ID: 2234204 [TBL] [Abstract][Full Text] [Related]
8. Hairy cell leukemia with bone marrow hypoplasia. Lee WM; Beckstead JH Cancer; 1982 Nov; 50(10):2207-10. PubMed ID: 6181863 [TBL] [Abstract][Full Text] [Related]
9. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment. Babuŝíková O; Tomová A; Kusenda J; Gyárfás J Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978 [TBL] [Abstract][Full Text] [Related]
10. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept. Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical characteristics of monocytoid B cell lymphoma, mantle zone lymphoma, small lymphocytic lymphoma (or B chronic lymphocytic leukemia), and hairy cell leukemia. Oka K; Mori N; Yatabe Y Acta Haematol; 1993; 90(2):84-9. PubMed ID: 8285023 [TBL] [Abstract][Full Text] [Related]
12. The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies. Falini B; Schwarting R; Erber W; Posnett DN; Martelli MF; Grignani F; Zuccaccia M; Gatter KC; Cernetti C; Stein H Am J Clin Pathol; 1985 Mar; 83(3):289-300. PubMed ID: 3156489 [TBL] [Abstract][Full Text] [Related]
13. Hairy cell leukemia: early immunophenotypical detection and quantitative analysis by flow cytometry. Babusíková O; Tomová A Neoplasma; 2003; 50(5):350-6. PubMed ID: 14628088 [TBL] [Abstract][Full Text] [Related]
14. Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin. Thaler J; Denz H; Dietze O; Gastl G; Ho AD; Gattringer C; Greil R; Lechleitner M; Huber C; Huber H Leuk Res; 1989; 13(5):377-83. PubMed ID: 2787447 [TBL] [Abstract][Full Text] [Related]
15. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens. Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460 [TBL] [Abstract][Full Text] [Related]
16. The monoclonal antibodies alpha S-HCL 1 (alpha Leu-14) and alpha S-HCL 3 (alpha Leu-M5) allow the diagnosis of hairy cell leukemia. Schwarting R; Stein H; Wang CY Blood; 1985 Apr; 65(4):974-83. PubMed ID: 3978236 [TBL] [Abstract][Full Text] [Related]
17. Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro. al-Katib A; Wang CY; McKenzie S; Clarkson BD; Koziner B Am J Hematol; 1992 Aug; 40(4):264-9. PubMed ID: 1354412 [TBL] [Abstract][Full Text] [Related]
19. Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia. Bardawil RG; Groves C; Ratain MJ; Golomb HM; Vardiman JW Am J Clin Pathol; 1986 Feb; 85(2):194-201. PubMed ID: 3946302 [TBL] [Abstract][Full Text] [Related]
20. Phorbol esters and hairy cell leukemia: effects on cell morphology and surface membrane features and comparison with other B cell leukemias. Polliack A; Leizerowitz R; Gazitt Y Leukemia; 1987 Apr; 1(4):311-5. PubMed ID: 3478538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]